Aceto Cp (ACET) 20.00 $ACET
What Makes Aceto (ACET) a Strong Sell?
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 9:14AM CDT
Aceto (ACET) has witnessed a significant price decline in the past four weeks, and it has lately seen negative earnings estimate revisions as well.
ACET: 20.00 (-0.03)
New Strong Sell Stocks for August 31st
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 9:46AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday
ACET: 20.00 (-0.03), BIDU: 177.78 (+1.23), AME: 49.15 (+0.37), BJRI: 39.66 (+0.44), ACRE: 12.65 (+0.11)
GameStop, Aceto fall sharply, while Rackspace Hosting gains
AP - Fri Aug 26, 3:33PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Friday:
ACET: 20.00 (-0.03), HLF: 61.35 (+0.18), RAX: 31.47 (unch), BIG: 49.89 (+0.49), FRGI: 25.49 (+0.18), ADSK: 68.01 (+0.64)
Watch for Aceto to Potentially Rebound After Falling 20.16% Yesterday
Comtex SmarTrend(R) - Fri Aug 26, 1:51PM CDT
Aceto (NASDAQ:ACET) traded in a range yesterday that spanned from a low of $20.28 to a high of $23.40. Yesterday, the shares fell 20.2%, which took the trading range below the 3-day low of $24.89 on volume of 1.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ACET: 20.00 (-0.03)
ACETO Reports Fiscal 2016 Fourth Quarter and Record Full Year Results
GlobeNewswire - Thu Aug 25, 4:42PM CDT
ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the fourth quarter and fiscal year ended June 30, 2016.
ACET: 20.00 (-0.03)
ACETO Board of Directors Increases Quarterly Cash Dividend by 8.3%
GlobeNewswire - Thu Aug 25, 2:29PM CDT
ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has increased its regular quarterly dividend to $0.065 per common share. This quarterly cash dividend will be distributed on September 20, 2016 to shareholders of record as of September 9, 2016.
ACET: 20.00 (-0.03)
ACETO Subsidiary, Rising Pharmaceuticals, to launch Fluocinolone Acetonide Body Oil, 0.01%, and Fluocinolone Acetonide Scalp Oil, 0.01%
GlobeNewswire - Tue Aug 23, 10:16AM CDT
ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, has launched two new products, Fluocinolone Acetonide Body Oil, 0.01%, an FDA approved generic version of Derma-Smoothe/FS Body Oil, and Fluocinolone Acetonide Scalp Oil, 0.01%, an FDA approved generic version of Derma-Smoothe/FS Scalp Oil.
ACET: 20.00 (-0.03)
ACETO Corporation Schedules Fourth Quarter & Fiscal 2016 Financial Results News Release and Conference Call
GlobeNewswire - Fri Aug 12, 7:35AM CDT
ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the fourth quarter of fiscal 2016 and the full fiscal year ended June 30, 2016 after the stock market close on Thursday, August 25, 2016.
ACET: 20.00 (-0.03)
ACETO to Present in June Conferences
GlobeNewswire - Mon May 23, 3:30PM CDT
ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced it will participate in two investor conferences taking place in June.
ACET: 20.00 (-0.03)
ACETO Reports Fiscal 2016 Third Quarter Results
GlobeNewswire - Thu May 05, 4:00PM CDT
ACETO Corporation (Nasdaq:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the third quarter of fiscal 2016 ended March 31, 2016.
ACET: 20.00 (-0.03)
ACETO Board of Directors Declares Quarterly Cash Dividend
GlobeNewswire - Thu May 05, 10:27AM CDT
ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common share. This quarterly cash dividend will be distributed on June 24, 2016 to shareholders of record as of June 9, 2016.
ACET: 20.00 (-0.03)
Humana (HUM) Q1 Earnings May Disappoint: Stock to Suffer?
Zacks Equity Research - Zacks Investment Research - Mon May 02, 7:51AM CDT
Humana Inc. (HUM) is set to report first-quarter 2016 results on May 4, before the market opens.
ACET: 20.00 (-0.03), BDX: 177.32 (+0.30), AET: 116.73 (+0.57), HUM: 177.33 (+0.80)
DaVita (DVA) Likely to Top Q1 Earnings: Stock to Gain?
Zacks Equity Research - Zacks Investment Research - Mon May 02, 7:08AM CDT
We expect DaVita HealthCare Partners Inc. (DVA) to beat expectations when it reports first-quarter 2016 results on May 4, after the market closes.
ACET: 20.00 (-0.03), BDX: 177.32 (+0.30), DVA: 64.78 (+0.59), BIND: 0.78 (-0.09)
ACETO Corporation Schedules Third Quarter & Fiscal 2016 Financial Results News Release and Conference Call
GlobeNewswire - Thu Apr 21, 7:31AM CDT
ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the third quarter of fiscal 2016 ended March 31, 2016 after the stock market close on Thursday, May 5, 2016.
ACET: 20.00 (-0.03)
ACETO to Present at the Needham & Company Healthcare Conference
GlobeNewswire - Thu Apr 07, 2:01PM CDT
ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Salvatore Guccione, President and CEO, will present at the Needham & Company Healthcare Conference on April 12, 2016 at 5:00 pm ET at the Westin New York Grand Central Hotel.
ACET: 20.00 (-0.03)
20.4% Return Seen to Date on SmarTrend Aceto Call (ACET)
Comtex SmarTrend(R) - Mon Feb 08, 11:37AM CST
SmarTrend identified a Downtrend for Aceto (NASDAQ:ACET) on December 14th, 2015 at $25.33. In approximately 2 months, Aceto has returned 20.41% as of today's recent price of $20.16.
ACET: 20.00 (-0.03)
Aceto posts 2Q profit
Automated Insights - Thu Feb 04, 5:11PM CST
PORT WASHINGTON, N.Y. (AP) _ Aceto Corp. (ACET) on Thursday reported fiscal second-quarter net income of $8.3 million.
ACET: 20.00 (-0.03)
ACETO Reports Fiscal 2016 Second Quarter Results
GlobeNewswire - Thu Feb 04, 4:00PM CST
ACETO Corporation (Nasdaq:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the second quarter of fiscal 2016 ended December 31, 2015.
ACET: 20.00 (-0.03)
ACETO Corporation Schedules Second Quarter & Fiscal 2016 Financial Results News Release and Conference Call
GlobeNewswire - Wed Jan 27, 5:59AM CST
ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the second quarter of fiscal 2016 ended December 31, 2015 after the stock market close on Thursday, February 4, 2016.
ACET: 20.00 (-0.03)
What Makes Aceto (ACET) a Strong Sell?
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 9:14AM CDT
Aceto (ACET) has witnessed a significant price decline in the past four weeks, and it has lately seen negative earnings estimate revisions as well.
ACET: 20.00 (-0.03)
New Strong Sell Stocks for August 31st
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 9:46AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday
ACET: 20.00 (-0.03), BIDU: 177.78 (+1.23), AME: 49.15 (+0.37), BJRI: 39.66 (+0.44), ACRE: 12.65 (+0.11)
GameStop, Aceto fall sharply, while Rackspace Hosting gains
AP - Fri Aug 26, 3:33PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Friday:
ACET: 20.00 (-0.03), HLF: 61.35 (+0.18), RAX: 31.47 (unch), BIG: 49.89 (+0.49), FRGI: 25.49 (+0.18), ADSK: 68.01 (+0.64)
Watch for Aceto to Potentially Rebound After Falling 20.16% Yesterday
Comtex SmarTrend(R) - Fri Aug 26, 1:51PM CDT
Aceto (NASDAQ:ACET) traded in a range yesterday that spanned from a low of $20.28 to a high of $23.40. Yesterday, the shares fell 20.2%, which took the trading range below the 3-day low of $24.89 on volume of 1.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ACET: 20.00 (-0.03)
ACETO Reports Fiscal 2016 Fourth Quarter and Record Full Year Results
GlobeNewswire - Thu Aug 25, 4:42PM CDT
ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the fourth quarter and fiscal year ended June 30, 2016.
ACET: 20.00 (-0.03)
ACETO Board of Directors Increases Quarterly Cash Dividend by 8.3%
GlobeNewswire - Thu Aug 25, 2:29PM CDT
ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has increased its regular quarterly dividend to $0.065 per common share. This quarterly cash dividend will be distributed on September 20, 2016 to shareholders of record as of September 9, 2016.
ACET: 20.00 (-0.03)
ACETO Subsidiary, Rising Pharmaceuticals, to launch Fluocinolone Acetonide Body Oil, 0.01%, and Fluocinolone Acetonide Scalp Oil, 0.01%
GlobeNewswire - Tue Aug 23, 10:16AM CDT
ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, has launched two new products, Fluocinolone Acetonide Body Oil, 0.01%, an FDA approved generic version of Derma-Smoothe/FS Body Oil, and Fluocinolone Acetonide Scalp Oil, 0.01%, an FDA approved generic version of Derma-Smoothe/FS Scalp Oil.
ACET: 20.00 (-0.03)
ACETO Corporation Schedules Fourth Quarter & Fiscal 2016 Financial Results News Release and Conference Call
GlobeNewswire - Fri Aug 12, 7:35AM CDT
ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the fourth quarter of fiscal 2016 and the full fiscal year ended June 30, 2016 after the stock market close on Thursday, August 25, 2016.
ACET: 20.00 (-0.03)
ACETO to Present in June Conferences
GlobeNewswire - Mon May 23, 3:30PM CDT
ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced it will participate in two investor conferences taking place in June.
ACET: 20.00 (-0.03)
ACETO Reports Fiscal 2016 Third Quarter Results
GlobeNewswire - Thu May 05, 4:00PM CDT
ACETO Corporation (Nasdaq:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the third quarter of fiscal 2016 ended March 31, 2016.
ACET: 20.00 (-0.03)
ACETO Board of Directors Declares Quarterly Cash Dividend
GlobeNewswire - Thu May 05, 10:27AM CDT
ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common share. This quarterly cash dividend will be distributed on June 24, 2016 to shareholders of record as of June 9, 2016.
ACET: 20.00 (-0.03)
Humana (HUM) Q1 Earnings May Disappoint: Stock to Suffer?
Zacks Equity Research - Zacks Investment Research - Mon May 02, 7:51AM CDT
Humana Inc. (HUM) is set to report first-quarter 2016 results on May 4, before the market opens.
ACET: 20.00 (-0.03), BDX: 177.32 (+0.30), AET: 116.73 (+0.57), HUM: 177.33 (+0.80)
DaVita (DVA) Likely to Top Q1 Earnings: Stock to Gain?
Zacks Equity Research - Zacks Investment Research - Mon May 02, 7:08AM CDT
We expect DaVita HealthCare Partners Inc. (DVA) to beat expectations when it reports first-quarter 2016 results on May 4, after the market closes.
ACET: 20.00 (-0.03), BDX: 177.32 (+0.30), DVA: 64.78 (+0.59), BIND: 0.78 (-0.09)
ACETO Corporation Schedules Third Quarter & Fiscal 2016 Financial Results News Release and Conference Call
GlobeNewswire - Thu Apr 21, 7:31AM CDT
ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the third quarter of fiscal 2016 ended March 31, 2016 after the stock market close on Thursday, May 5, 2016.
ACET: 20.00 (-0.03)
ACETO to Present at the Needham & Company Healthcare Conference
GlobeNewswire - Thu Apr 07, 2:01PM CDT
ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Salvatore Guccione, President and CEO, will present at the Needham & Company Healthcare Conference on April 12, 2016 at 5:00 pm ET at the Westin New York Grand Central Hotel.
ACET: 20.00 (-0.03)
20.4% Return Seen to Date on SmarTrend Aceto Call (ACET)
Comtex SmarTrend(R) - Mon Feb 08, 11:37AM CST
SmarTrend identified a Downtrend for Aceto (NASDAQ:ACET) on December 14th, 2015 at $25.33. In approximately 2 months, Aceto has returned 20.41% as of today's recent price of $20.16.
ACET: 20.00 (-0.03)
Aceto posts 2Q profit
Automated Insights - Thu Feb 04, 5:11PM CST
PORT WASHINGTON, N.Y. (AP) _ Aceto Corp. (ACET) on Thursday reported fiscal second-quarter net income of $8.3 million.
ACET: 20.00 (-0.03)
ACETO Reports Fiscal 2016 Second Quarter Results
GlobeNewswire - Thu Feb 04, 4:00PM CST
ACETO Corporation (Nasdaq:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the second quarter of fiscal 2016 ended December 31, 2015.
ACET: 20.00 (-0.03)
ACETO Corporation Schedules Second Quarter & Fiscal 2016 Financial Results News Release and Conference Call
GlobeNewswire - Wed Jan 27, 5:59AM CST
ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the second quarter of fiscal 2016 ended December 31, 2015 after the stock market close on Thursday, February 4, 2016.
ACET: 20.00 (-0.03)
